Assessment of Consumer Knowledge of New Sunscreen Labels

Study concept and design: Narang, Dogra. Acquisition, analysis, or interpretation of data: Narang, Sawatkar, Kumaran. Drafting of the manuscript: Narang, Sawatkar, Kumaran. Critical revision of the manuscript for important intellectual content: Dogra. Statistical analysis: Sawatkar. Administrative, technical, or material support: Dogra. Study supervision: Narang, Kumaran, Dogra. Conflict of Interest Disclosures: None reported. 1. Motta AC, Pereira KJ, Tarquínio DC, Vieira MB, Miyake K, Foss NT. Leprosy reactions. Clinics (Sao Paulo). 2012;67(10):1145-1148. 2. Pocaterra L, Jain S, Reddy R, et al. Clinical course of erythema nodosum leprosum. Am J Trop Med Hyg. 2006;74(5):868-879. 3. Kumar B, Dogra S, Kaur I. Epidemiological characteristics of leprosy reactions. Int J Lepr Other Mycobact Dis. 2004;72(2):125-133. 4. Garrido-Mesa N, Zarzuelo A, Gálvez J. Minocycline: far beyond an antibiotic. Br J Pharmacol. 2013;169(2):337-352. 5. El-Khalawany M, Shaaban D, Sultan M, Abd Alsalam F. Inhibition of angiogenesis as a new therapeutic target in the treatment of lepromatous leprosy. Clin Cosmet Investig Dermatol. 2012;5:1-6. 6. Maia MV, Cunha Mda G, Cunha CS. Adverse effects of alternative therapy (minocycline, ofloxacin, and clofazimine) in multibacillary leprosy patients in a recognized health care unit in Manaus, Amazonas, Brazil. An Bras Dermatol. 2013;88(2):205-210.